Bionano Genomics BNGO Income Statement (2017-2026)

NASDAQ BNGO
$1.18 -0.02 (-1.67%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Bionano Genomics Quarterly Income Statement

Periods 36 quarters
Latest Jun 2026

Bionano Genomics reported revenue of $8.17M and net income of -$7.42M for the quarter ended Jun 2026, up 21.4% year over year. This income statement covers 36 quarters of results from Sep 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
4.66M6.30M5.70M6.67M7.22M8.21M7.42M8.66M9.32M10.72M8.77M7.77M6.07M8.16M6.46M6.73M7.37M7.95M6.69M8.17M
Cost of RevenueCost of Rev
3.50M6.06M4.83M5.20M5.41M6.41M5.34M6.35M6.57M8.28M5.95M5.19M14.52M0.16M3.52M3.26M4.00M4.55M3.44M3.86M
Gross Profit
1.15M0.24M0.86M1.47M1.81M1.80M2.07M2.31M2.75M2.44M2.82M2.58M-8.45M8.01M2.94M3.48M3.37M3.40M3.25M4.31M
Operating items
Research & DevelopmentR&D
6.50M9.21M10.53M11.77M12.74M14.01M13.94M14.61M13.79M11.70M9.78M6.83M4.72M3.47M2.37M2.93M2.84M3.23M3.14M2.99M
Selling, General & AdministrativeSG&A
15.33M19.81M20.28M21.78M21.22M25.32M25.98M26.94M24.90M14.95M19.09M11.56M9.46M11.75M9.03M8.35M9.06M8.71M8.01M8.54M
Restructuring CostsRestructuring
0.74M4.63M1.22M1.77M0.20M
Other Operating ExpensesOther Opex
77.28M0.45M19.50M-0.06M
Operating ExpensesOpex
21.83M29.02M30.80M33.55M33.96M39.33M39.91M41.55M115.96M27.39M33.95M19.60M35.45M15.36M11.40M11.28M11.91M11.94M11.15M11.53M
Operating IncomeOp. Inc
-20.68M-28.78M-29.94M-32.08M-32.15M-37.53M-37.84M-39.24M-113.21M-24.95M-31.12M-17.02M-43.90M-11.94M-8.46M-7.80M-8.54M-8.54M-7.90M-7.22M
EBIT
-20.68M-28.78M-29.94M-32.08M-32.15M-37.53M-37.84M-39.24M-113.21M-24.95M-31.12M-17.02M-43.90M-11.94M-8.46M-7.80M-8.54M-8.54M-7.90M-7.22M
Non-operating items
Non Operating Interest Expenses
0.00M0.03M0.08M0.07M0.07M0.07M0.08M0.07M0.07M4.90M0.12M
Interest & Investment IncomeInt & Inv Inc
0.03M0.08M0.11M0.19M0.44M0.77M0.70M0.69M0.73M1.19M1.04M0.46M0.38M0.23M0.29M0.28M0.27M0.28M0.22M0.15M
Other Non Operating IncomeOther Non Op Inc.
-0.07M-0.02M-0.03M-0.16M0.01M-0.04M0.12M-0.33M-0.04M-20.16M-1.36M0.36M-0.70M-8.41M5.08M0.68M-0.22M0.36M-0.62M-0.34M
Non Operating IncomeNon Op. Inc.
-0.04M0.07M-0.04M0.37M0.66M0.74M0.36M0.69M-18.97M-0.32M0.82M-0.32M-8.18M5.37M0.95M0.05M0.64M-0.40M-0.20M
Net income details
EBT
-20.72M-28.72M-29.94M-32.12M-31.78M-36.87M-37.10M-38.88M-112.53M-43.93M-31.44M-16.20M-44.22M-20.56M-3.10M-6.85M-8.49M-8.02M-8.29M-7.42M
Tax ProvisionsTaxes
0.04M-5.77M0.01M0.04M0.03M1.80M0.03M0.03M0.04M-0.04M-0.02M0.03M0.02M-23.55M0.01M0.01M0.01M-5.56M0.01M0.01M
Profit After TaxPAT
-20.75M-22.95M-29.95M-32.16M-31.81M-38.68M-37.12M-38.91M-112.57M-43.89M-31.42M-16.22M-44.25M-20.12M-3.10M-6.86M-8.50M-7.93M-8.30M-7.42M
Income from Continuing OperationsIncome (Continuing)
-20.75M-22.95M-29.95M-32.16M-31.81M-38.68M-37.12M-38.91M-112.57M-43.89M-31.42M-16.22M-44.25M2.99M-3.10M-6.86M-8.50M-2.46M-8.30M-7.42M
Consolidated Net IncomeConsol Net Inc.
-20.75M-22.95M-29.95M-32.16M-31.81M-38.68M-37.12M-38.91M-112.57M-43.89M-31.42M-16.22M-44.25M2.99M-3.10M-6.86M-8.50M-2.46M-8.30M-7.42M
Income towards Parent CompanyParent Net Inc
-20.75M-22.95M-29.95M-32.16M-31.81M-38.68M-37.12M-38.91M-112.57M-43.89M-31.42M-16.22M-44.25M2.99M-3.10M-6.86M-8.50M-2.46M-8.30M-7.42M
Net Income towards Common StockholdersNet Income
-20.75M-22.95M-29.95M-32.16M-31.81M-38.68M-37.12M-38.91M-112.57M-43.89M-31.42M-16.22M-44.25M2.99M-3.10M-6.86M-8.50M-2.46M-8.30M-7.42M
Additional items
EPS (Basic)
-0.74-0.83-1.05-1.13-1.10-1.34-1.23-1.24-3.22-1.29-0.60-0.24-0.522.35-1.15-1.99-1.59-0.45-0.76-0.64
EPS (Diluted)
-0.74-0.83-1.05-1.13-1.10-1.34-1.23-1.24-3.22-1.29-0.60-0.24-0.522.35-1.15-1.99-1.59-0.45-0.76-0.64
Shares Outstanding
28.02M27.68M28.46M28.56M28.97M28.92M30.20M31.50M35.00M34.15M52.74M67.58M85.87M1.27M2.69M3.44M5.34M5.45M10.98M11.55M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
28.02M27.68M28.46M28.56M28.97M28.92M30.20M31.50M35.00M34.15M52.74M67.58M85.87M1.27M2.69M3.44M5.34M5.45M10.98M11.55M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
28.14M28.96M28.97M29.01M29.69M29.72M30.68M33.24M35.35M34.15M57.54M70.78M88.47M1.27M3.10M3.91M5.34M5.45M11.28M11.78M
EBITDA
-20.68M-28.78M-29.94M-32.08M-32.15M-37.53M-37.84M-39.24M-113.21M-24.95M-31.12M-17.02M-43.90M-11.94M-8.46M-7.80M-8.54M-8.54M-7.90M-7.22M
Interest ExpensesInt Expense
0.00M0.03M0.08M0.07M0.07M0.07M0.08M0.07M0.07M4.90M0.12M
Tax Rate
-0.17%20.08%-0.03%-0.13%-0.09%-4.90%-0.07%-0.08%-0.03%0.08%0.06%-0.16%-0.05%114.53%-0.23%-0.15%-0.16%69.34%-0.12%-0.09%